116 related articles for article (PubMed ID: 38836387)
1. A chiral trimethyl lock based on the
Venturi S; Chiaradonna F; Gatti FG; La Ferla B; Palorini R; Zerbato B
Chem Commun (Camb); 2024 Jun; 60(51):6524-6527. PubMed ID: 38836387
[TBL] [Abstract][Full Text] [Related]
2. Self-assembling nanowires of an amphiphilic camptothecin prodrug derived from homologous derivative conjugation.
He D; Zhang W; Deng H; Huo S; Wang YF; Gong N; Deng L; Liang XJ; Dong A
Chem Commun (Camb); 2016 Dec; 52(98):14145-14148. PubMed ID: 27869268
[TBL] [Abstract][Full Text] [Related]
3. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
4. A DT-diaphorase responsive theranostic prodrug for diagnosis, drug release monitoring and therapy.
Liu P; Xu J; Yan D; Zhang P; Zeng F; Li B; Wu S
Chem Commun (Camb); 2015 Jun; 51(46):9567-70. PubMed ID: 25971544
[TBL] [Abstract][Full Text] [Related]
5. A series of camptothecin prodrugs exhibit HDAC inhibition activity.
Zhu Q; Yu X; Shen Q; Zhang Q; Su M; Zhou Y; Li J; Chen Y; Lu W
Bioorg Med Chem; 2018 Sep; 26(16):4706-4715. PubMed ID: 30115492
[TBL] [Abstract][Full Text] [Related]
6. Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: An intelligent tumor-targeted delivery nanoplatform.
Huang Y; Zhang W; Xu Y; Zhu S; Wu Y; Chen T; Xiao Y; Lu W; Zhang X; Yu J
Int J Pharm; 2020 Apr; 580():119250. PubMed ID: 32209369
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
[TBL] [Abstract][Full Text] [Related]
8. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.
Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873
[TBL] [Abstract][Full Text] [Related]
9. GSH-Responsive supramolecular nanoparticles constructed by β-d-galactose-modified pillar[5]arene and camptothecin prodrug for targeted anticancer drug delivery.
Liu X; Shao W; Zheng Y; Yao C; Peng L; Zhang D; Hu XY; Wang L
Chem Commun (Camb); 2017 Jul; 53(61):8596-8599. PubMed ID: 28718478
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine-camptothecin conjugates: a hybrid prodrug for controlled drug release and synergistic therapeutics.
Hou M; Xue P; Gao YE; Ma X; Bai S; Kang Y; Xu Z
Biomater Sci; 2017 Aug; 5(9):1889-1897. PubMed ID: 28681888
[TBL] [Abstract][Full Text] [Related]
11. A camptothecin-based, albumin-binding prodrug enhances efficacy and safety in vivo.
Cheng Z; Huang Y; Shen Q; Zhao Y; Wang L; Yu J; Lu W
Eur J Med Chem; 2021 Dec; 226():113851. PubMed ID: 34547508
[TBL] [Abstract][Full Text] [Related]
12. Reduction-Responsive Chemo-Capsule-Based Prodrug Nanogel for Synergistic Treatment of Tumor Chemotherapy.
Lu Y; Jia D; Ma X; Liang M; Hou S; Qiu W; Gao Y; Xue P; Kang Y; Xu Z
ACS Appl Mater Interfaces; 2021 Feb; 13(7):8940-8951. PubMed ID: 33565847
[TBL] [Abstract][Full Text] [Related]
13. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
14. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting.
Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z
Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739
[TBL] [Abstract][Full Text] [Related]
15. Monodisperse oligoethylene glycols modified Camptothecin, 10-Hydroxycamptothecin and SN38 prodrugs.
Deng T; Mao X; Xiao Y; Yang Z; Zheng X; Jiang ZX
Bioorg Med Chem Lett; 2019 Feb; 29(4):581-584. PubMed ID: 30600208
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-Triggered Piezocatalysis for Selectively Controlled NO Gas and Chemodrug Release to Enhance Drug Penetration in Pancreatic Cancer.
Wang Y; Tang Q; Wu R; Sun S; Zhang J; Chen J; Gong M; Chen C; Liang X
ACS Nano; 2023 Feb; 17(4):3557-3573. PubMed ID: 36775922
[TBL] [Abstract][Full Text] [Related]
17. Dendritic polymer prodrug-based unimolecular micelles for pH-responsive co-delivery of doxorubicin and camptothecin with synergistic controlled drug release effect.
Chen W; Liu P
Colloids Surf B Biointerfaces; 2024 Jun; 238():113906. PubMed ID: 38615388
[TBL] [Abstract][Full Text] [Related]
18. Encapsulation and Controlled Release of a Camptothecin Prodrug from Nanocarriers and Microgels: Tuning Release Rate with Nanocarrier Excipient Composition.
Wilson BK; Sinko PJ; Prud'homme RK
Mol Pharm; 2021 Mar; 18(3):1093-1101. PubMed ID: 33440941
[TBL] [Abstract][Full Text] [Related]
19. Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing.
Ao M; Yu F; Li Y; Zhong M; Tang Y; Yang H; Wu X; Zhuang Y; Wang H; Sun X; Hong X; Chen XD
J Nanobiotechnology; 2021 Oct; 19(1):350. PubMed ID: 34717646
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, self-assembly and drug release behaviors of a bottlebrush polymer-HCPT prodrug for tumor chemotherapy.
Lv F; Liu D; Cong H; Shen Y; Yu B
Colloids Surf B Biointerfaces; 2019 Sep; 181():278-284. PubMed ID: 31154138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]